SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001513160-11-000041
Filing Date
2011-07-11
Accepted
2011-07-11 19:02:44
Documents
1
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2955
  Complete submission text file 0001513160-11-000041.txt   4549
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GMID 12100 WILSHIRE BLVD., SUITE 800 LOS ANGELES CA 90025
Business Address
Saloff David (Reporting) CIK: 0001375530 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-08092 | Film No.: 11962758